NHS England (2013 data) suggests that approximately 14 million people live with persistent or chronic pain in the UK. This affects their health, quality of life and ability to work. Napp have been committed to furthering the understanding and treatment of pain for over 35 years.
Palladone® SR capsules, IR capsules, and solution for injection or infusion (hydromorphone hydrochloride)
SPC PILAdverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUK@napp.co.uk.
The following websites are independent sites offering support, information and resources for people with pain:
Please note that these websites are owned and managed by patient organisations/charities, Napp is not responsible for any of the content within these websites.
You are now leaving our website. Napp does not accept any responsibility for the third party site.
Please click "Continue to external link" if you want to proceed.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy